US Patent Issued to Japan Tobacco on Nov. 4 for "Therapeutic or preventing agent for multiple sclerosis including indole compound" (Japanese Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,458,646, issued on Nov. 4, was assigned to Japan Tobacco Inc. (Tokyo).

"Therapeutic or preventing agent for multiple sclerosis including indole compound" was invented by Yoshifumi Ueda (Takatsuki, Japan), Takafumi Kurimoto (Takatsuki, Japan) and Naofumi Uesato (Takatsuki, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a therapeutic agent or prophylactic agent for multiple sclerosis, containing N-[2-(6,6-dimethyl-4,5,6,7-tetrahydro-1H-indazol-3-yl)-1H-indol-6-yl]-N-methyl-(2S)-2-(morpholin-4-yl)propanamide or a pharmaceutically acceptable salt thereof."

The patent was filed on May 24, 2019, under Application No. 17/05...